US SB1897 | 2019-2020 | 116th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on June 19 2019 - 25% progression, died in committee
Action: 2019-06-19 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on June 19 2019 - 25% progression, died in committee
Action: 2019-06-19 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to establish a process for updating the labeling of certain drugs with outdated labeling.
Title
A bill to establish a process for updating the labeling of certain drugs with outdated labeling.
Sponsors
| Sen. Michael Bennet [D-CO] | Sen. Michael Enzi [R-WY] |
History
| Date | Chamber | Action |
|---|---|---|
| 2019-06-19 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Same As/Similar To
SB1895 (Related) 2019-07-08 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 133.
HB5668 (Related) 2020-11-18 - Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
HB5668 (Related) 2020-11-18 - Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Subjects
Congressional oversight
Drug safety, medical device, and laboratory regulation
Health
Prescription drugs
Drug safety, medical device, and laboratory regulation
Health
Prescription drugs
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/116th-congress/senate-bill/1897/all-info |
| Text | https://www.congress.gov/116/bills/s1897/BILLS-116s1897is.pdf |
